JP2022534501A - 三環式化合物 - Google Patents

三環式化合物 Download PDF

Info

Publication number
JP2022534501A
JP2022534501A JP2021570378A JP2021570378A JP2022534501A JP 2022534501 A JP2022534501 A JP 2022534501A JP 2021570378 A JP2021570378 A JP 2021570378A JP 2021570378 A JP2021570378 A JP 2021570378A JP 2022534501 A JP2022534501 A JP 2022534501A
Authority
JP
Japan
Prior art keywords
optionally substituted
alkyl
compound
unsubstituted
heterocyclyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2021570378A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022534501A5 (cg-RX-API-DMAC7.html
Inventor
サンドリーヌ ヴァンドヴィル
Original Assignee
アリゴス セラピューティクス インコーポレイテッド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by アリゴス セラピューティクス インコーポレイテッド filed Critical アリゴス セラピューティクス インコーポレイテッド
Publication of JP2022534501A publication Critical patent/JP2022534501A/ja
Publication of JP2022534501A5 publication Critical patent/JP2022534501A5/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
JP2021570378A 2019-05-30 2020-05-27 三環式化合物 Pending JP2022534501A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962854597P 2019-05-30 2019-05-30
US62/854,597 2019-05-30
PCT/US2020/034746 WO2020243199A1 (en) 2019-05-30 2020-05-27 Tricyclic compounds

Publications (2)

Publication Number Publication Date
JP2022534501A true JP2022534501A (ja) 2022-08-01
JP2022534501A5 JP2022534501A5 (cg-RX-API-DMAC7.html) 2023-05-30

Family

ID=73552666

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021570378A Pending JP2022534501A (ja) 2019-05-30 2020-05-27 三環式化合物

Country Status (19)

Country Link
US (1) US11136321B2 (cg-RX-API-DMAC7.html)
EP (1) EP3976618A4 (cg-RX-API-DMAC7.html)
JP (1) JP2022534501A (cg-RX-API-DMAC7.html)
KR (1) KR20220016177A (cg-RX-API-DMAC7.html)
CN (1) CN113906029A (cg-RX-API-DMAC7.html)
AU (1) AU2020282707B2 (cg-RX-API-DMAC7.html)
BR (1) BR112021023967A2 (cg-RX-API-DMAC7.html)
CA (1) CA3138938A1 (cg-RX-API-DMAC7.html)
CL (1) CL2021003139A1 (cg-RX-API-DMAC7.html)
CO (1) CO2021017202A2 (cg-RX-API-DMAC7.html)
EA (1) EA202192760A1 (cg-RX-API-DMAC7.html)
IL (1) IL287813A (cg-RX-API-DMAC7.html)
MA (1) MA56058A (cg-RX-API-DMAC7.html)
MX (1) MX2021014458A (cg-RX-API-DMAC7.html)
PE (1) PE20220427A1 (cg-RX-API-DMAC7.html)
PH (1) PH12021552953A1 (cg-RX-API-DMAC7.html)
SG (1) SG11202113214QA (cg-RX-API-DMAC7.html)
TW (1) TW202110845A (cg-RX-API-DMAC7.html)
WO (1) WO2020243199A1 (cg-RX-API-DMAC7.html)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20220000874A1 (en) * 2019-05-30 2022-01-06 Aligos Therapeutics, Inc. Tricyclic compounds
US12703701B2 (en) * 2019-12-10 2026-08-11 Shanghai Hansoh Biomedical Co., Ltd. Pyrazole-containing polycyclic derivative inhibitor, preparation method therefor and application thereof
GB202103704D0 (en) * 2021-03-17 2021-04-28 Pathios Therapeutics Ltd Compounds
WO2022115384A1 (en) * 2020-11-24 2022-06-02 Aligos Therapeutics, Inc. Tricyclic compounds

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008090379A1 (en) * 2007-01-24 2008-07-31 Istituto Di Ricerche Di Biologia Molecolare P. Angeletti Spa Pyrazoloquinazolinones as inhibitors of poly(adp-ribose)polymerase (parp)
WO2008157273A1 (en) * 2007-06-14 2008-12-24 Smithkline Beecham Corporation Chemical compounds
JP2016535043A (ja) * 2013-10-29 2016-11-10 メディヴィル・アクチエボラーグ キナゾリンベースの呼吸器合胞体ウイルス阻害剤
WO2018219356A1 (en) * 2017-06-01 2018-12-06 Sunshine Lake Pharma Co., Ltd. Fused tricyclic compounds and uses thereof in medicine

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112018068177B1 (pt) 2016-03-09 2024-02-27 Emory University Composto, uso do composto e composição para eliminação do vírus da hepatite b com agentes antivirais

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008090379A1 (en) * 2007-01-24 2008-07-31 Istituto Di Ricerche Di Biologia Molecolare P. Angeletti Spa Pyrazoloquinazolinones as inhibitors of poly(adp-ribose)polymerase (parp)
WO2008157273A1 (en) * 2007-06-14 2008-12-24 Smithkline Beecham Corporation Chemical compounds
JP2016535043A (ja) * 2013-10-29 2016-11-10 メディヴィル・アクチエボラーグ キナゾリンベースの呼吸器合胞体ウイルス阻害剤
WO2018219356A1 (en) * 2017-06-01 2018-12-06 Sunshine Lake Pharma Co., Ltd. Fused tricyclic compounds and uses thereof in medicine

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
ZHEN FANG ET AL.: "Discovery of pyrazolo[1,5-a]pyrimidine-3-carbonitrile derivatives as a new class of histone lysine d", BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, vol. 27, no. 14, JPN6023024954, 2017, pages 3201 - 3204, ISSN: 0005085803 *

Also Published As

Publication number Publication date
BR112021023967A2 (pt) 2022-03-08
MA56058A (fr) 2022-04-06
TW202110845A (zh) 2021-03-16
CL2021003139A1 (es) 2022-09-23
EP3976618A1 (en) 2022-04-06
CN113906029A (zh) 2022-01-07
EP3976618A4 (en) 2023-01-04
PH12021552953A1 (en) 2022-07-25
US20200407361A1 (en) 2020-12-31
CO2021017202A2 (es) 2022-01-17
MX2021014458A (es) 2022-01-06
WO2020243199A1 (en) 2020-12-03
EA202192760A1 (ru) 2022-03-05
PE20220427A1 (es) 2022-03-29
SG11202113214QA (en) 2021-12-30
CA3138938A1 (en) 2020-12-03
AU2020282707A1 (en) 2021-12-02
AU2020282707B2 (en) 2025-06-19
US11136321B2 (en) 2021-10-05
KR20220016177A (ko) 2022-02-08
IL287813A (en) 2022-01-01

Similar Documents

Publication Publication Date Title
KR102085121B1 (ko) 이미다조[1,2-b]피리다진계 화합물, 그를 포함하는 조성물 및 그의 용도
ES2649144T3 (es) Compuestos heteroaromáticos y su uso como ligandos de dopamina D1
US11952374B2 (en) Bicyclic compounds
US11136321B2 (en) Tricyclic compounds
KR102641566B1 (ko) 바이사이클릭 및 트라이사이클릭 화합물
CA3134635A1 (en) Pyrrole compounds
TW202237606A (zh) 三環化合物
US11957683B2 (en) Bicyclic compounds
KR20210126636A (ko) 이환식 설폰아마이드
JP2009513640A (ja) Hivインテグラーゼインヒビター
AU2021360496A9 (en) Bicyclic compounds
US20220000874A1 (en) Tricyclic compounds
AU2023353869A1 (en) Bicyclic compounds
EP4511374A1 (en) Bicyclic compounds

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20230522

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20230522

A871 Explanation of circumstances concerning accelerated examination

Free format text: JAPANESE INTERMEDIATE CODE: A871

Effective date: 20230522

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20230619

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20230919

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20240226